Investor Alert: Brodsky & Smith Announces Investigations into Several Public Companies

Brodsky & Smith, a law firm based in BALA CYNWYD, PA, has announced a series of investigations on behalf of shareholders into several publicly traded companies. The aim is to determine whether these companies have upheld fiduciary duties and complied with federal securities laws.

Details on Companies Under Scrutiny

The investigations address concerns related to potential malfeasance or misleading business practices within the following companies:

AZN - AstraZeneca PLC, with extensive operations in developing prescription drugs targeting numerous health challenges, from its base in Cambridge, United Kingdom. TFII - TFI International Inc., which specializes in transportation and logistics across North America, headquartered in Saint-Laurent, Canada. KRTX - Karuna Therapeutics, Inc., a biopharmaceutical company focused on psychiatric and neurological conditions, based in Boston, Massachusetts. DSKE - Daseke, Inc., known for its transportation and logistics services with a focus on flatbed and specialized freight, operating from Addison, Texas. RYZB - RayzeBio, Inc., a San Diego-based company developing cancer treatments through radiopharmaceutical therapeutics (RPT). BMY - Bristol-Myers Squibb, a global pharmaceutical company with a wide range of therapeutic products, headquartered in New York City.

Contact Information for Shareholders

Shareholders who currently own stocks in these companies and are concerned about their investments are encouraged to get in touch with Brodsky & Smith to discuss their legal rights. Attorneys Jason Brodsky ([email protected]) and Marc Ackerman ([email protected]) can be reached at 855-576-4847 for a no-cost, no-obligation conversation regarding the ongoing investigations.

Investor, Alert, Investigations